Search results
USFDA gives tentative nod to Alembic Pharma’s generic formulation to treat leukemia
Financial Express· 1 day agoBosutinib Tablets have an estimated market size of US$ 275 million for twelve months ending March...
Alembic Pharma stock rallies 5% after firm receives USFDA tentative approval for Bosutinib tablets
CNBC Awaaz· 21 hours agoAlembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (...
Alembic Pharma gains nearly 5% on tentative USFDA nod for leukemia drug - CNBC TV18
CNBC TV18· 23 hours agoIn a filing to the stock exchanges, the company said that it has received tentative approval from...
Cipla - USFDA Inspection At Company'S Manufacturing Facility In Goa, India.
CNBC Awaaz· 1 day agoCipla - USFDA Inspection At Company'S Manufacturing Facility In Goa, India.
USFDA highlights quality concerns over drugs manufactured in India
Business Standard India· 5 days agoUSFDA India drug inspections: USFDA launches QMM program to reduce drug shortages and improve supply...
Indian firms fared better in USFDA inspections in recent years, says IPA
Business Standard India· 6 days agoMeanwhile, there has been a notable improvement in India’s performance when it comes to US FDA...
Wockhardt shares skyrocket 18% to fresh 52-week high. Here’s why?
The Economic Times· 24 hours agoThe hospital (Children's Hospital of Orange County) sought access to Zaynich, for a young...
USFDA gives nod to Lupin’s generic formulation to treat eye condition
Financial Express· 5 days agoOlopatadine Hydrochloride Ophthalmic Solution USP (RLD Pataday) had an estimated annual sale of USD...
Alembic Pharma gets final USFDA nod for Inflammatory Lesions Capsules - CNBC TV18
CNBC TV18· 4 days agoAlembic Pharmaceuticals Ltd has received final approval from the United States Food and Drug...
India has a stable record on USFDA compliances, says study
The Hindu· 7 days agoThe Indian pharmaceutical industry has been stable in terms of its regulatory compliance record for the United States compared to other emerging markets, says CareEdge Ratings. The number of ...